PharmaCyte Biotech, Inc.

PMCB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
225
SEC Filings

Business Summary

PART I . We are a biotechnology company focused on developing cellular therapies for cancer based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including LAPC, will be developed. The current generation of our product candidate is referred to as CypCaps. During the year ended April 30, 2024, we determined that research and development ...

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPMCBdiscussed_in_filing Cybersecurity
topic_mentionPMCBdiscussed_in_filing Trusted Computing
topic_mentionPMCBdiscussed_in_filing Blockchain & Crypto
topic_mentionPMCBdiscussed_in_filing Supply Chain
topic_mentionPMCBdiscussed_in_filing Regulation
topic_mentionPMCBdiscussed_in_filing Healthcare & Bio
topic_mentionPMCBdiscussed_in_filing Platform & Ecosystem
topic_mentionPMCBdiscussed_in_filing Sovereign & Government
topic_mentionPMCBdiscussed_in_filing Cybersecurity
topic_mentionPMCBdiscussed_in_filing Trusted Computing
topic_mentionPMCBdiscussed_in_filing Blockchain & Crypto
topic_mentionPMCBdiscussed_in_filing Supply Chain
topic_mentionPMCBdiscussed_in_filing Regulation
topic_mentionPMCBdiscussed_in_filing Healthcare & Bio
topic_mentionPMCBdiscussed_in_filing Platform & Ecosystem
topic_mentionPMCBdiscussed_in_filing Sovereign & Government
topic_mentionPMCBdiscussed_in_filing Cybersecurity
topic_mentionPMCBdiscussed_in_filing Trusted Computing
topic_mentionPMCBdiscussed_in_filing Blockchain & Crypto
topic_mentionPMCBdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-08-112025-04-300001683168-25-005821EDGAR103K words
2024-08-132024-04-300001683168-24-005575EDGAR
2023-07-312023-04-300001683168-23-005175EDGAR
2022-07-282022-04-300001683168-22-005189EDGAR
2021-08-102021-04-300001683168-21-003377EDGAR
2020-08-132020-04-300001683168-20-002680EDGAR
2019-08-132019-04-300001683168-19-002559EDGAR
2018-07-202018-04-300001683168-18-001994EDGAR
2017-07-272017-04-300001683168-17-001881EDGAR
2016-07-292016-04-300001019687-16-007057EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-172026-01-310001683168-26-001917EDGAR30K words
2025-12-182025-10-310001683168-25-009259EDGAR
2025-09-152025-07-310001683168-25-006991EDGAR
2025-03-172025-01-310001683168-25-001669EDGAR
2024-12-132024-10-310001683168-24-008709EDGAR
2024-09-172024-07-310001683168-24-006441EDGAR
2024-03-182024-01-310001683168-24-001525EDGAR
2023-12-152023-10-310001683168-23-008889EDGAR
2023-09-182023-07-310001683168-23-006505EDGAR
2023-03-162023-01-310001683168-23-001559EDGAR
2022-12-142022-10-310001683168-22-008428EDGAR
2022-09-142022-07-310001683168-22-006394EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001683168-26-002613EDGAR12K words
2025-12-050001683168-25-008947EDGAR
2025-10-310001683168-25-007871EDGAR
2025-09-050001683168-25-006727EDGAR
2025-08-180001683168-25-006274EDGAR
2025-04-240001683168-25-002790EDGAR
2025-02-260001683168-25-001236EDGAR
2024-05-230001683168-24-003796EDGAR
2024-05-010001683168-24-002881EDGAR
2023-11-240001683168-23-008446EDGAR

225 total filings indexed. 193 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001157075
TickerPMCB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ee4e658770ed2c55c057711e91c6d4123e2ca76cb871cbae86ec36d981e97e10
parent: a3fab153e9ee8b3aa29a3d3f48170b66d29e2b228cd6e6b358d8167450a974e9
content hash: ba1856748609f8a9c7fe02166a28cf08e3c8122e468af3d418409e378f800401
signed: 2026-04-13T04:46:56.444Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf